Shelly Cayette-Weston, President of Business Operations for the Charlotte Hornets, discusses the team’s strategic initiatives to enhance the fan experience and drive economic development in Charlotte. She speaks with Romaine Bostick and Bailey Lipschultz on “The Close.” (Source: Bloomberg)
Shelly Cayette-Weston, President of Business Operations for the Charlotte Hornets, discusses the team’s strategic initiatives to enhance the fan experience and drive economic development in Charlotte. She speaks with Romaine Bostick and Bailey Lipschultz on “The Close.” (Source: Bloomberg)
Paramount Skydance Corp. ’s takeover of Warner Bros. Discovery Inc. is expected to feature an unusual combination of investment-grade and junk-rated debt, as Wall Street banks turn to as many markets as possible to raise $57.5 billion of debt for the acquisition. A trio of lenders are initially providing temporary financing, which will be refinanced with about two-thirds or more investment-grade d...
Paramount Skydance Corp. ’s takeover of Warner Bros. Discovery Inc. is expected to feature an unusual combination of investment-grade and junk-rated debt, as Wall Street banks turn to as many markets as possible to raise $57.5 billion of debt for the acquisition. A trio of lenders are initially providing temporary financing, which will be refinanced with about two-thirds or more investment-grade debt and the rest in high-yield bonds, according to people familiar with the matter. Typically, borrowers opt for either investment-grade financing or leveraged financing, rarely both in combination. The high-grade debt is expected to include loans and senior secured bonds, while the junk bonds will likely be unsecured, said the people who asked not to be identified discussing private deliberations. Banks are set to be invited to join the syndicate in the coming weeks, the people said. Lenders have already asked to get on the deal, vying for a spot on the high-profile financing. The company expects to borrow in dollars and euros, with financing expected to wrap up by the end of summer, they said. The high-stakes bidding war for Warner Bros. ended this week after Paramount raised its offer to $31 a share. Netflix Inc. , which had previously agreed to buy most of Warner Bros. for $27.75 a share, declined to match it. Read more: Netflix Drops Warner Bros. Bid, Leaving Paramount the Winner (3) Bank of America Corp. , Citigroup Inc. and Apollo Global Management Inc. are providing the $57.5 billion bridge loan. For lenders, underwriting mergers and acquisitions is one of the most lucrative businesses. Representatives for Paramount, Bank of America, Citi and Apollo declined to comment. A spokesperson for Warner Bros. didn’t immediately respond to a request for comment. Read more: Banks Pounce on M&A Revival With $100 Billion of Buyout Debt (1) Getting Creative While the majority of the debt in the LBO will be high-grade, there’s poised to be roughly $18 billion of junior unsecured ...
DAVE INC (DAVE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
DAVE INC (DAVE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
tupungato/iStock Editorial via Getty Images Introduction Capital markets haven't been kind to software companies lately; the sector that was once beloved for having near-zero marginal costs, recurring revenue, and an asset-light operational nature has recently witnessed massive drawdowns as investors fear that AI agents will replace most software functionality, leading to massive user churn, reven...
tupungato/iStock Editorial via Getty Images Introduction Capital markets haven't been kind to software companies lately; the sector that was once beloved for having near-zero marginal costs, recurring revenue, and an asset-light operational nature has recently witnessed massive drawdowns as investors fear that AI agents will replace most software functionality, leading to massive user churn, revenue declines, and margin compression. Even though these fears feel validated given that there is a swath of SaaS companies trading at massive multiples while providing marginal value to end consumers, the market has certainly overreacted on this one name that possesses a deep moat, high operational efficiency, double-digit top line growth, and enough capital and investments to benefit from this compute revolution, and that name is Microsoft Corporation ( MSFT ). YTD, Microsoft's stock has declined by more than 20%, while its mega-cap peers only declined by single-digits. This drawdown is underserved for a company that has dominated the software industry for decades, proving management's tenacity and drive to maintain the innovative streak that enabled the firm to survive multiple tech revolutions. This time is no different, and if anything, to me it looks like the AI revolution will likely benefit incumbents rather than startups, given the upfront capital required for training and inference. This overreaction is giving investors that seek quality names an opportunity to benefit from MSFT's upside as the market corrects. Among the Mag 7 names, Microsoft was one of the names that underperformed the SPDR® S&P 500 ETF Trust ( SPY ) and the Roundhill Magnificent Seven ETF ( MAGS ) on a 1-year performance, losing 5% of its value while MAGS and the SPY returned 16.59% and 15.07%, respectively. The outperformance of these ETFs was largely influenced by the massive rally of Alphabet ( GOOG ), which returned 72.33% YoY, outperforming both ETFs and its mega-cap peers. YoY performance (...
tupungato/iStock Editorial via Getty Images Introduction Capital markets haven't been kind to software companies lately; the sector that was once beloved for having near-zero marginal costs, recurring revenue, and an asset-light operational nature has recently witnessed massive drawdowns as investors fear that AI agents will replace most software functionality, leading to massive user churn, reven...
tupungato/iStock Editorial via Getty Images Introduction Capital markets haven't been kind to software companies lately; the sector that was once beloved for having near-zero marginal costs, recurring revenue, and an asset-light operational nature has recently witnessed massive drawdowns as investors fear that AI agents will replace most software functionality, leading to massive user churn, revenue declines, and margin compression. Even though these fears feel validated given that there is a swath of SaaS companies trading at massive multiples while providing marginal value to end consumers, the market has certainly overreacted on this one name that possesses a deep moat, high operational efficiency, double-digit top line growth, and enough capital and investments to benefit from this compute revolution, and that name is Microsoft Corporation ( MSFT ). YTD, Microsoft's stock has declined by more than 20%, while its mega-cap peers only declined by single-digits. This drawdown is underserved for a company that has dominated the software industry for decades, proving management's tenacity and drive to maintain the innovative streak that enabled the firm to survive multiple tech revolutions. This time is no different, and if anything, to me it looks like the AI revolution will likely benefit incumbents rather than startups, given the upfront capital required for training and inference. This overreaction is giving investors that seek quality names an opportunity to benefit from MSFT's upside as the market corrects. Among the Mag 7 names, Microsoft was one of the names that underperformed the SPDR® S&P 500 ETF Trust ( SPY ) and the Roundhill Magnificent Seven ETF ( MAGS ) on a 1-year performance, losing 5% of its value while MAGS and the SPY returned 16.59% and 15.07%, respectively. The outperformance of these ETFs was largely influenced by the massive rally of Alphabet ( GOOG ), which returned 72.33% YoY, outperforming both ETFs and its mega-cap peers. YoY performance (...
Simon Gallagher, Managing Director at SPG Global, says Netflix’s outlook remains strong even without Warner Bros. Discovery content. He speaks with Romaine Bostick and Bailey Lipschultz on “The Close.” (Source: Bloomberg)
Simon Gallagher, Managing Director at SPG Global, says Netflix’s outlook remains strong even without Warner Bros. Discovery content. He speaks with Romaine Bostick and Bailey Lipschultz on “The Close.” (Source: Bloomberg)
Alondra Nelson, Harold F. Linder Professor at the Institute for Advanced Study and a member of the UN advisory body on AI, says she doesn’t believe Anthropic is going anywhere, noting that much can change in the next six months. She speaks with Romaine Bostick and Bailey Lipschultz on “The Close.” (Source: Bloomberg)
Alondra Nelson, Harold F. Linder Professor at the Institute for Advanced Study and a member of the UN advisory body on AI, says she doesn’t believe Anthropic is going anywhere, noting that much can change in the next six months. She speaks with Romaine Bostick and Bailey Lipschultz on “The Close.” (Source: Bloomberg)
Vance Says 'No Chance' Strikes On Iran Would Become A Prolonged War Just to underscore how close we are to witnessing an American military attack on Iran, this is the current scene at Israel's Ben Gurion International Airport... I don’t think that people understand how unusual this picture is #Iran https://t.co/72itsQunEn — Nadav Pollak (@NadavPollak) February 27, 2026 On Thursday Vice President J...
Vance Says 'No Chance' Strikes On Iran Would Become A Prolonged War Just to underscore how close we are to witnessing an American military attack on Iran, this is the current scene at Israel's Ben Gurion International Airport... I don’t think that people understand how unusual this picture is #Iran https://t.co/72itsQunEn — Nadav Pollak (@NadavPollak) February 27, 2026 On Thursday Vice President JD Vance issued some curious and eyebrow-raising comments to The Washington Post regarding the looming prospect of unprovoked attack on Iran. Vance asserted that there's "no chance" military strikes on Iran would result in the United States becoming involved in a prolonged war . Speaking with The Washington Post on Air Force Two, he explained Trump is weighing military and diplomatic options to prevent Iran from obtaining a nuclear weapon - but Vance also sought to defend repeat promises previously given on the campaign trail which decried America's prior addiction to regime change wars and foreign quagmires . "The idea that we're going to be in a Middle Eastern war for years with no end in sight - there is no chance that will happen," Vance said. But if there's one thing the American public has learned after 20+ years of the so-called Global War on Terror, it's not to trust a politician when he says "trust me" concerning a 'limited' attack not becoming a disastrous entanglement. Political leaders might say one thing, but Americans by and large hear another... Vance is a Marine Corp combat veteran who has himself admitted he was "lied to" over the Iraq war, the architects of which were the Bush Neocons. Vance has at times even described himself as a "skeptic of foreign military interventions." The VP further told the Post that "I think we all prefer the diplomatic option" - however, "it really depends on what the Iranians do and what they say," he explained. And yet there's no controlling Iran's response should the US send missiles on Tehran or its nuclear sites. The Iranian...
Vir Biotechnology Vir is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. The company on Monday announced new data from the ongoing Phase 1 clinical trial of VIR-5500, a prostate-specific membrane antigen (PSMA)-targeting, PRO-XTEN dual-masked T-cell engager (TCE) ...
Vir Biotechnology Vir is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. The company on Monday announced new data from the ongoing Phase 1 clinical trial of VIR-5500, a prostate-specific membrane antigen (PSMA)-targeting, PRO-XTEN dual-masked T-cell engager (TCE) being evaluated in patients with advanced metastatic castration-resistant prostate cancer (mCRPC) who have progressed after multiple lines of therapy. These data suggest that VIR-5500 monotherapy is well tolerated and exhibits promising anti-tumor activity. Vir CEO Marianne De Backer discusses the progress being made with the firm's leading treatments, the runup in its share price thus far in 2026, and why partnerships are key to advancing Vir's impact. Dr. De Backer speaks with Carol Massar and Tim Stenovec on Bloomberg Businessweek Daily. (Source: Bloomberg)
Boarding1Now/iStock Editorial via Getty Images Delta Air Lines ( DAL ) said post-market Friday it will buy 34 more Airbus ( EADSF ) ( EADSY ) A321neo jets, its third aircraft order in less than six weeks, as the carrier continues its plan to refresh its fleet with aircraft that burn less fuel and offer more premium seats. Delta ( DAL ) said the order lifts its total commitment for the A321neo to 1...
Boarding1Now/iStock Editorial via Getty Images Delta Air Lines ( DAL ) said post-market Friday it will buy 34 more Airbus ( EADSF ) ( EADSY ) A321neo jets, its third aircraft order in less than six weeks, as the carrier continues its plan to refresh its fleet with aircraft that burn less fuel and offer more premium seats. Delta ( DAL ) said the order lifts its total commitment for the A321neo to 189 aircraft; with 92 of the jets currently in service and firm orders for another 97, including the latest option exercise; the carrier also holds options for 36 additional A321neos. The company said the A321neo offers the lowest unit cost of any narrowbody jet in its fleet and is 20%–30% more fuel efficient than the current generation aircraft it replaces and carries more first-class and extra-legroom seats than any other narrowbody in its fleet. Last month, Delta ( DAL ) announced separate orders for 30 Boeing 787 Dreamliners and 31 Airbus ( EADSF ) ( EADSY ) A330-900 and A350-900 widebody jets. More on Delta Air Lines Delta Air Lines: Deleveraging, Margin Discipline, And Valuation Upside From Turbulence To Takeoff: Why Delta Could Become A Solid Dividend Grower Delta Air Lines: This Overlooked Catalyst Supports My Buy Rating
The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -0.43%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.30%. March E-mini S&P futures (ESH26 ) fell -0.47%, and March E-mini Nasdaq futures...
The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -0.43%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.30%. March E-mini S&P futures (ESH26 ) fell -0.47%, and March E-mini Nasdaq futures...
It isn't typical for beleaguered alt-protein food product specialist Beyond Meat (NASDAQ: BYND) to have a good day on the stock market, but that's what occurred on Friday. After the company announced the dramatic expansion of a new product line, investors piled into its equity, and Beyond Meat shares closed the trading session more than 15% higher. Beyond Meat announced that it has rolled out four...
It isn't typical for beleaguered alt-protein food product specialist Beyond Meat (NASDAQ: BYND) to have a good day on the stock market, but that's what occurred on Friday. After the company announced the dramatic expansion of a new product line, investors piled into its equity, and Beyond Meat shares closed the trading session more than 15% higher. Beyond Meat announced that it has rolled out four new flavors of its Beyond Immerse line of sparkling drinks. Customers wishing to quaff the company's offerings infused with plant-based protein, fiber, electrolytes, and antioxidants can now opt for cherry berry, strawberry lemonade, cucumber grapefruit, or piña colada flavors. Image source: Getty Images. Continue reading
Accenture (ACN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Accenture (ACN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.